60 related articles for article (PubMed ID: 37329728)
21. Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis.
Park JN; Agee T; McCormick S; Felsher M; Collins K; Hsu J; Schweizer N; Lucas G; Falade-Nwulia O
J Addict Med; 2023 Sep-Oct 01; 17(5):608-611. PubMed ID: 37788619
[TBL] [Abstract][Full Text] [Related]
22. Substance Use Treatment Utilization Among Individuals With Substance Use Disorders in the United States During the COVID-19 Pandemic: Findings on the Role of Polysubstance Use, Criminal Justice Involvement, and Mental Illness From the National Survey on Drug Use and Health.
Apsley HB; Santos-Lozada AR; Gray J; Hard G; Jones AA
Subst Use; 2024; 18():29768357241259947. PubMed ID: 38881556
[TBL] [Abstract][Full Text] [Related]
23. Understanding the preference for receiving mental health and substance use support in African Americans 50 and older.
Usidame B; McQueen Gibson E; Diallo A; Blondino C; Clifford J; ; Zanjani F; Sargent L; Price E; Slattum P; Parsons P; Prom-Wormley E
J Prev Interv Community; 2023; 51(3):268-286. PubMed ID: 34053408
[TBL] [Abstract][Full Text] [Related]
24. Stigma Toward Substance Dependence: Causes, Consequences, and Potential Interventions.
Krendl AC; Perry BL
Psychol Sci Public Interest; 2023 Nov; 24(2):90-126. PubMed ID: 37883667
[TBL] [Abstract][Full Text] [Related]
25. Substance use problems and disorders among adults 50 years and older receiving mental health treatment for a primary neurocognitive disorder.
Ware OD; Baik S; Becker TD; Neukrug H; Zimmerman S
Aging Ment Health; 2024 Mar; ():1-6. PubMed ID: 38533723
[TBL] [Abstract][Full Text] [Related]
26. The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016-17 ENCODAT Cohort.
Medina-Mora ME; Genis-Mendoza AD; Villatoro Velázquez JA; Bustos-Gamiño M; Bautista CF; Camarena B; Martínez-Magaña JJ; Nicolini H
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833803
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of validity of US survey measures for assessing substance use and substance use disorders.
Tang Y; Caswell E; Mohamed R; Wilson N; Osmanovic E; Smith G; Hartley SD; Bhandari R
Syst Rev; 2024 Jun; 13(1):166. PubMed ID: 38937847
[TBL] [Abstract][Full Text] [Related]
28. Toward a Public Health Surveillance System for Behavioral Health.
Lyerla R; Stroup DF
Public Health Rep; 2018; 133(4):360-365. PubMed ID: 29746207
[No Abstract] [Full Text] [Related]
29. Sociodemographic profiles and determinants of relapse risks among people with substance use disorders in the Philippines: A survey in community and residential care settings.
Harada T; Kanamori S; Baba T; Takano A; Nomura K; Villaroman A; Rey FI; Peralta J; Shirasaka T
Drug Alcohol Depend; 2023 Oct; 251():110924. PubMed ID: 37633130
[TBL] [Abstract][Full Text] [Related]
30. How policymakers innovate around behavioral health: adoption of the New Mexico "No Behavioral Health Cost-Sharing" law.
Harris SJ; Golberstein E; Maclean JC; Stein BD; Ettner SL; Saloner B
Health Aff Sch; 2024 Jan; 2(1):qxad081. PubMed ID: 38756394
[TBL] [Abstract][Full Text] [Related]
31. Physical Exercise to Redynamize Interoception in Substance use Disorders.
Brevers D; Billieux J; de Timary P; Desmedt O; Maurage P; Perales JC; Suárez-Suárez S; Bechara A
Curr Neuropharmacol; 2024; 22(6):1047-1063. PubMed ID: 36918784
[TBL] [Abstract][Full Text] [Related]
32. The role of lifestyle in perpetuating substance use disorder: the Lifestyle Balance Model.
Davies G; Elison S; Ward J; Laudet A
Subst Abuse Treat Prev Policy; 2015 Jan; 10():2. PubMed ID: 25595205
[TBL] [Abstract][Full Text] [Related]
33. Statistical Methods and Software for Substance Use and Dependence Genetic Research.
Lan T; Yang B; Zhang X; Wang T; Lu Q
Curr Genomics; 2019 Apr; 20(3):172-183. PubMed ID: 31929725
[TBL] [Abstract][Full Text] [Related]
34. Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults.
Choi NG; DiNitto DM; Marti CN
Drug Alcohol Depend; 2014 Dec; 145():113-20. PubMed ID: 25456572
[TBL] [Abstract][Full Text] [Related]
35. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants.
Cucciare MA; Ounpraseuth ST; Curran GM; Booth BM
Subst Abus; 2019; 40(3):363-370. PubMed ID: 30810499
[No Abstract] [Full Text] [Related]
36. Trends in cigarette use and health insurance coverage among US adults with mental health and substance use disorders.
Creedon TB; Wayne GF; Progovac AM; Levy DE; Cook BL
Addiction; 2023 Feb; 118(2):353-364. PubMed ID: 36385708
[TBL] [Abstract][Full Text] [Related]
37. The representation of females in clinical trials for substance use disorder conducted in the United States (2010-19).
Gunn CM; Pankowska M; Harris M; Helsing E; Battaglia TA; Bagley SM
Addiction; 2022 Oct; 117(10):2583-2590. PubMed ID: 35165969
[TBL] [Abstract][Full Text] [Related]
38. Annual use and perceived need for mental health and substance treatment among people in remission from substance use disorders in the United States.
Hayes BB
Drug Alcohol Depend; 2023 Aug; 249():110820. PubMed ID: 37329728
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
